Micronutrient Levels and Nutritional Status in Critical Illness
NUTRI-ICU
1 other identifier
observational
79
1 country
1
Brief Summary
Rationale: A significant proportion of patients admitted to the Intensive Care Unit (ICU) is unable to fully recover, even when the initial cause of their illness has been treated. Inadequate dietary intake prior to admission and during the recovery phase may leave patients in a frail physical state, limiting rehabilitation potential. Commonly used methods to assess nutritional intake and nutritional status are highly impacted by various disease-related confounders and reporting bias. We hypothesise that a combined assessment of biomarkers in plasma and urine may provide a more accurate overview of nutritional status at ICU-admission. Objective: Main: Assess nutrition-related biomarkers in plasma and urine samples at ICU admission Secondary: Identify the number of micronutrient deficiencies at ICU admission Compare biomarker profile and dietary intake of short and long-stay ICU patients at baseline Compare subjective dietary intake, nutritional status and muscle thickness between patients with and without micronutrient deficiencies at baseline Study design: Observational study Study population: Adult patients admitted to the ICU. Two groups will be recruited: patients with a short length of stay (\<48 hours) and patients with a longer length of stay (≥48 hours). Main study parameters: Biomarker status in blood and urine at ICU admission. Nature and extent of the burden and risks associated with participation, benefit and group relatedness: In addition to standard care ICU treatment, the following measurements will be performed:
- Within 24 hours after admission blood and urine samples will be collected from existing venous line and urinary catheter
- Within 72 hours an ultrasound measurement of the upper leg will be performed.
- During ICU stay, when the patient is capable to do so, they will be asked to complete a retrospective dietary intake assessment. The risks and negative effects of these tests are limited. However, this study asks for a time investment and physical and mental effort of the patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 8, 2023
CompletedFirst Submitted
Initial submission to the registry
July 3, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 3, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 3, 2023
CompletedFirst Posted
Study publicly available on registry
November 7, 2023
CompletedNovember 21, 2024
March 1, 2024
5 months
July 3, 2023
November 19, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Number of biomarker deficits at ICU admission
Total number of biomarker deficts at ICU admission, based on data collected within 24 hours after admission on: Markers general health: haemoglobin (Hb), mean corpuscular volume (MCV), glucose, c-reactive protein (CRP), thyroid stimulating hormone (TSH), creatinine + glomerular filtration rate (eGFR), alanine aminotransferase (ALAT), urea, albumin, total protein, lipid profile Micronutrients: potassium, calcium, sodium, vit B11, vit B1, vit B6, vit B12, vit D, Vit C, ferritin, magnesium, chloride, phosphorus
at ICU admission
Secondary Outcomes (2)
Dietary intake
at ICU admission
Physical health
at ICU admission
Other Outcomes (2)
Patient characteristics
at ICU admission
Clinical data
at ICU admission
Study Arms (2)
Short stay
Patients admitted to the ICU with a need for mechanical ventilation of less than 48 hours
Long stay
Patients admitted to the ICU with a need for mechanical ventilation of 48 hours or more
Interventions
Eligibility Criteria
All patients admitted to the ICU within six months after start of the study (March-August 2023) will be asked for consent to participate in this study. A maximum of 50 'short stay' (\<48 hours admitted) patients will be included. These patients will only participate in the baseline measurements. Patients that are eligible for the standard post-ICU outpatient clinic at three months (≥48 hours admitted/ventilated) will be invited for additional study measurements at the standard care outpatient visit at three months after admission.
You may qualify if:
- Age: 18 years and above.
You may not qualify if:
- Not proficient in speaking and/or understanding Dutch
- Comorbidity highly affecting gut absorption (e.g. post-bariatric surgery)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Frisius Medisch Centrumlead
- University of Groningencollaborator
Study Sites (1)
Medical Centre Leeuwarden
Leeuwarden, 8934AD, Netherlands
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
July 3, 2023
First Posted
November 7, 2023
Study Start
May 8, 2023
Primary Completion
October 3, 2023
Study Completion
October 3, 2023
Last Updated
November 21, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share